pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

20,113 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: recall×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Mar 9, 2026

    27
    ›Mar 11, 2026recall172d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Cleansing Towelette (Benzalkonium Chloride 0.13%), 5"x 7", 1,000 case/Bulk, Med-Nap, Brooksville, FL 34601, Made in USA, NDC 0924-0243-00. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall172d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    WP WipesPlus Hand Sanitizing Wipes (Benzalkonium Chloride 0.13%), 5x7, 100 CT, Progressive Products, 211 S. Ridge Street, Rye Brook, NY 10573. NDC 67151-727-01. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall172d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    1) BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) 5"x7" Piedmont Sanitizing Hand Wipes, 1,000 ea Bulk, Made in USA for: Food Service Resources, Flowery Branch, GA 30542, NDC 0924-7130-00. 2) BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) 5" x 7" Touchpoint, 1000 ea Bulk, Made in USA for : Food Service Resources, Flowery Branch, GA 30542. NDC 0924-7130-00. 3) BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) 5" x 7" Wellstar Cobb Hand Wipes, 1000 ea Bulk, Made in the USA for Food Service Resources, Flowery Branch, GA 30542, NDC 0924-7130-00. 4) BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) 5" x 7" FSR Sanitizing Hand Wipes, 1000 ea Bulk, Made in USA for Food Service Resources, Flowery Branch, GA 30542, NDC 0924-7130-00. Inner Packaging - Instant Hand Sanitizing Wipes 5) BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) 5" x7" Children's 1000 ea Bulk, Made in USA for: Food Service Resources, Flowery Branch, GA 30542 NDC 0924-713-00. Inner packaging -Children's Healthcare of Atlanta — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall172d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054. — Reason: Failed Dissolution Specifications — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall172d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Children's Healthcare of Atlanta, Instant Hand Sanitizing Wipe(Benzalkonium Chloride 0.13%), 1000 per case, Made in USA for Food Service Resources, Flowery Branch, GA 30542, NDC 0924-7130-00 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall172d agoANTHONY TRINH, 123Herbals LLC recall (Cls I)Viatris Inc

    SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China — Reason: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 12, 2026approval171d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

    Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 12, 2026approval171d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

    Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 12, 2026approval171d agoPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN HYDROBROMIDE) — FDA approvalPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE

    Sponsor: HETERO LABS LTD III. Form: SYRUP. Route: ORAL

    full page →PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE →fda approvals ↗
    ›Mar 12, 2026approval171d agoTRULICITY (DULAGLUTIDE) — FDA approvaldulaglutide

    Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION

    full page →dulaglutide →fda approvals ↗
    ›Mar 12, 2026approval171d agoSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalToujeo LA

    Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →Toujeo LA →fda approvals ↗
    ›Mar 12, 2026approval171d agoPOTASSIUM PHOSPHATES (POTASSIUM PHOSPHATE, DIBASIC) — FDA approvalHospira Inc

    Sponsor: CAPLIN. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 12, 2026approval171d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

    Sponsor: BIOCON LTD. Form: CAPSULE. Route: ORAL

    full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗
    ›Mar 12, 2026approval171d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

    Sponsor: BIOCON LTD. Form: CAPSULE. Route: ORAL

    full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗
    ›Mar 12, 2026approval171d agoADLYXIN (LIXISENATIDE) — FDA approvalADLYXIN

    Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ADLYXIN →fda approvals ↗
    ›Mar 12, 2026approval171d agoSUNLENCA (LENACAPAVIR SODIUM) — FDA approvallenacapavir sodium LA

    Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →lenacapavir sodium LA →fda approvals ↗
    ›Mar 12, 2026approval171d agoSUNLENCA (LENACAPAVIR SODIUM) — FDA approvallenacapavir sodium LA

    Sponsor: GILEAD SCIENCES INC. Form: TABLET. Route: ORAL

    full page →lenacapavir sodium LA →fda approvals ↗
    ›Mar 12, 2026approval171d agoPOMALIDOMIDE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 13, 2026approval170d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Mar 13, 2026approval170d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

    Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

    full page →Daptomycin Novo →fda approvals ↗
    ›Mar 13, 2026approval170d agoMEFENAMIC ACID — FDA approvalMEFENAMIC ACID

    Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL

    full page →MEFENAMIC ACID →fda approvals ↗
    ›Mar 13, 2026approval170d agoGEMCITABINE HYDROCHLORIDE — FDA approvalGEMCITABINE HYDROCHLORIDE

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →GEMCITABINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 13, 2026approval170d agoALLOPURINOL SODIUM — FDA approvalALLOPURINOL SODIUM

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →ALLOPURINOL SODIUM →fda approvals ↗
    ›Mar 13, 2026approval170d agoALLOPURINOL SODIUM — FDA approvalALLOPURINOL SODIUM

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →ALLOPURINOL SODIUM →fda approvals ↗
    ›Mar 13, 2026approval170d agoMETHOTREXATE — FDA approvalMaxtrex

    Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →Maxtrex →fda approvals ↗
    ›Mar 13, 2026approval170d agoPHYTONADIONE — FDA approvalSigyn Therapeutics, Inc.

    Sponsor: ORBICULAR. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 13, 2026approval170d agoCITALOPRAM HYDROBROMIDE — FDA approvalCITALOPRAM HYDROBROMIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

    full page →CITALOPRAM HYDROBROMIDE →fda approvals ↗

    Week of Mar 16, 2026

    23
    ›Mar 16, 2026approval167d agoNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalrimegepant sulfate ODT

    Sponsor: PFIZER. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →rimegepant sulfate ODT →fda approvals ↗
    ›Mar 16, 2026approval
    ← prev
    page 393 of 403
    next →
    167d ago
    FLUTICASONE PROPIONATE — FDA approvalFluticasone Propionate Glenmark

    Sponsor: GLENMARK PHARMS LTD. Form: SPRAY, METERED. Route: NASAL

    full page →Fluticasone Propionate Glenmark →fda approvals ↗
    ›Mar 16, 2026approval167d agoDESOXIMETASONE — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Mar 16, 2026approval167d agoACAMPROSATE CALCIUM — FDA approvalacamprosate calcium DR

    Sponsor: APPCO. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →acamprosate calcium DR →fda approvals ↗
    ›Mar 16, 2026approval167d agoDESOXIMETASONE — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Mar 16, 2026approval167d agoERIBULIN MESYLATE — FDA approvalEisai Co Ltd

    Sponsor: XGEN PHARMS. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 16, 2026approval167d agoELTROMBOPAG — FDA approval

    Sponsor: DR REDDYS. Form: TABLET

    full page →fda approvals ↗
    ›Mar 16, 2026approval167d agoLAMOTRIGINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 16, 2026approval167d agoLAMOTRIGINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 17, 2026approval166d agoALYFTREK (DEUTIVACAFTOR) — FDA approval(deutivacaftor + tezacaftor + vanzacaftor calcium)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →(deutivacaftor + tezacaftor + vanzacaftor calcium) →fda approvals ↗
    ›Mar 17, 2026approval166d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →TRIKAFTA (COPACKAGED) →fda approvals ↗
    ›Mar 17, 2026approval166d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

    Sponsor: VERTEX PHARMS INC. Form: GRANULES. Route: ORAL

    full page →TRIKAFTA (COPACKAGED) →fda approvals ↗
    ›Mar 17, 2026approval166d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

    Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

    full page →(ivacaftor + lumacaftor) →fda approvals ↗
    ›Mar 17, 2026approval166d agoICOTYDE (ICOTROKINRA HYDROCHLORIDE) — FDA approvalicotrokinra hydrochloride

    Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL

    full page →icotrokinra hydrochloride →fda approvals ↗
    ›Mar 17, 2026approval166d agoKALYDECO (IVACAFTOR) — FDA approvalVertex, Inc.

    Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 17, 2026approval166d agoAK-FLUOR 25% (FLUORESCEIN SODIUM) — FDA approvalLong Grove Pharmaceuticals LLC

    Sponsor: LONG GROVE PHARMS. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 17, 2026approval166d agoOXALIPLATIN — FDA approvalOXALIPLATIN

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

    full page →OXALIPLATIN →fda approvals ↗
    ›Mar 17, 2026approval166d agoOXALIPLATIN — FDA approvalOXALIPLATIN

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

    full page →OXALIPLATIN →fda approvals ↗
    ›Mar 17, 2026approval166d agoKALYDECO (IVACAFTOR) — FDA approvalivacaftor

    Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

    full page →ivacaftor →fda approvals ↗
    ›Mar 17, 2026approval166d agoPIROXICAM — FDA approvalNostrum Pharmaceuticals LLC

    Sponsor: UNICHEM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 17, 2026approval166d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →(ivacaftor + lumacaftor) →fda approvals ↗
    ›Mar 17, 2026approval166d agoSYMDEKO (COPACKAGED) (IVACAFTOR) — FDA approvalivacaftor

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →ivacaftor →fda approvals ↗
    ›Mar 17, 2026approval166d agoLYNAVOY (LINERIXIBAT) — FDA approvallinerixibat

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →linerixibat →fda approvals ↗
    $ACU45.90-1.54%
    $ACU45.90-1.54%
    $ACU45.90-1.54%
    $TERN52.95-0.03%
    $ACU45.90-1.54%
    $VTRS16.34-3.26%
    $NVS153.81-0.54%
    $NVS153.81-0.54%
    $LLY1174.61-0.13%
    $GILD145.68-2.14%
    $PFE27.96-0.21%
    $VERX14.22-0.52%
    $VERX14.22-0.52%
    $SIGY0.04000.00%
    $GILD145.68-2.14%
    $VERX14.22-0.52%
    $VERX14.22-0.52%
    $VERX14.22-0.52%
    $VERX14.22-0.52%
    $VERX14.22-0.52%
    $VERX14.22-0.52%